QUNR [Qunar Cayman Islands] F-1/A: (Original Filing)

[CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered (1) (2) Proposed Maximum (4) Amount Of Class B Ordinary shares, par value US$0.001 per share (3) US$125,000,000 US$17,050 (1) (2) (3) American depositary shares issuable upon deposit of the Class B ordinary shares registered hereby will be registered under a separate registration statement on Form F-6] [Business Cooperation Framework Agreement BUSINESS COOPERATION FRAMEWORK AGREEMENT Agreement (a) Qunar Qunar Cayman Islands Limited, a Cayman Islands exempted company (“ (b) Baidu Baidu, Inc., a Cayman Islands exempted company (“ Parties Party Qunar and Baidu, are hereinafter collectively referred to as the “ W I T N E S S E T H: Whereas, the Parties agree to further] [Consent of Independent Registered Public Accounting Firm We consent to the reference to our firm under the caption “Experts” and to the use of our report dated April 12, 2013, in Amendment No. 1 to the Registration Statement (Form F-1 No. 333-191459) and related Prospectus of Qunar Cayman Islands Limited for the registration of its ordinary shares. Beijing, People’s Republic]

CO [China Cord Blood] CORRESP: (Original Filing)

[October 2, 2013 John Reynolds Re: China Cord Blood Corporation Registration Statement on Form F-3 Filed September 12, 2013 File No. 333-191121 Dear Mr. Reynolds: We hereby provide responses to comments issued on September 26, 2013 (the “Staff’s Letter”) regarding the Registration Statement on Form F-3 (File No. 333-191121)(the “F-3”) of China Cord Blood Corporation (the “Company”). In order to]

By | 2016-02-29T13:11:56+00:00 October 2nd, 2013|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

GSI [GENERAL STEEL] 8-K: (Original Filing)

[General Steel Receives Notice Regarding NYSE Listing Criteria Under NYSE rules, the Company has 45 days from the date of the notice to submit a plan to the NYSE demonstrating its ability to achieve compliance with the continued listing standards within 18 months of receiving the notice. The Company intends to submit such plan and has notified the NYSE that] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): September 26, 2013 General Steel Holdings, Inc. Nevada 001-33717 41-2079252 (State or other jurisdiction (IRS Employer of incorporation) Identification Number) Level 21, Tower B, Jia Ming Center No. 27 Dong San Huan North Road Chaoyang District, Beijing, China 100020 + 86 (10) 57757691 (Former name or former address,]

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[TPI Announces Fiscal Year 2013 Financial Results September 27, 2013 Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the fiscal year 2013. Fiscal Year 2013 Ended June 30, 2013 Financial Highlights: · Revenue was $67.5 million compared] [Tianyin Pharmaceutical Inc. Fiscal Year 2013 Annual Financial Results Conference Call September 27, 2013 Operator James Tong - Chief Financial Officer. Financial highlights of Fiscal year 2013 ended June 30, 2013: Revenue totaled $67.5 million compared with $69.6 million in fiscal year 2012, a decrease of 3% year-over-year. Operating income was $9.3 million, compared with $8.5 million in fiscal year] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT September 27, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By | 2016-03-27T18:10:03+00:00 October 2nd, 2013|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] CORRESP: (Original Filing)

[October 2, 2013 John Reynolds Re: Chinard Bloodrporation Registration Statement on Form F-3 Filed September 12, 2013 File No. 333-191121 Dear Mr. Reynolds: We hereby provide responses tomments issued on September 26, 2013 (the Staffs Letter) regarding the Registration Statement on Form F-3 (File No. 333-191121)(the F-3) of Chinard Bloodrporation (thempany).]

By | 2016-02-04T15:43:08+00:00 October 2nd, 2013|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

SIMO [Silicon Motion Technology] 6-K: (Original Filing)

[Silicon Motion Announces Quarterly Dividend Taipei, Taiwan, October 1, 2013 – Silicon Motion Technology Corporation (NasdaqGS: SIMO) (“Silicon Motion” or the “Company”), a global leader in designing and marketing NAND flash controllers for solid state storage devices and specialty RF IC solutions for mobile devices, announces today its next quarterly cash dividend. The Board of Directors of the Company has] [Press Release issued by the Company on October 1, 2013. ILICON OTION ECHNOLOGY ORPORATION S]

By | 2016-03-14T18:30:56+00:00 October 2nd, 2013|Categories: Chinese Stocks, SEC Original, SIMO|Tags: , , , , , |0 Comments

VNET [21Vianet] 6-K: (Original Filing)

[21VIANET ANNOUNCES US$100 MILLION INVESTMENT FROM TEMASEK BEIJING “We welcome Temasek’s investment in our Company and believe that its deep expertise in Asia’s telecom industry will significantly benefit 21Vianet going forward,” said Mr. Josh Chen, co-founder, chairman and chief executive officer of 21Vianet. “With this investment from one of the most reputable investment companies in Asia, 21Vianet can better leverage] [FORM 6-K 21Vianet Group, Inc. M5, 1 Jiuxianqiao East Road, Chaoyang District Beijing 100016 The People’s Republic of China (86 10) 8456 2121 x ¨ Form 20-F ¨ ¨ 21Vianet Group, Inc. Shang-Wen Hsiao Chief Financial Officer 6-K 1 d608402d6k.htm FORM 6-K]

Skip to toolbar